Sign In
Buy GBT
$68.49
+0 (+0%)
At Close: Jan 27, 2023
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Vertex Pharmaceuticals (VRTX) and Teladoc (TDOC)
01:46pm, Thursday, 30'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Humana (HUM), Vertex Pharmaceuticals (VRTX) and Teladoc
Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Vertex Pharmaceuticals (NASDAQ: VRTX) and Teladoc (NYSE: TDOC)
01:46pm, Thursday, 30'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Humana (
HUM
–
Research Report
), Vertex Pharmaceuticals (
VRTX
–
Research Report
) and Teladoc (
T
GBT to Announce First Quarter 2020 Financial Results on Wednesday, May 6, 2020
12:00pm, Wednesday, 29'th Apr 2020
SOUTH SAN FRANCISCO, Calif., April 29, 2020 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report first quarter 2020 financial results on.
NEW YORK, April 29, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Global Blood.
Global Blood Therapeutics (NASDAQ:GBT) Now Covered by Stifel Nicolaus
09:50am, Wednesday, 29'th Apr 2020
Equities researchers at Stifel Nicolaus initiated coverage on shares of Global Blood Therapeutics (NASDAQ:GBT) in a research report issued on Monday, Marketbeat Ratings reports. The firm set a “buy�
Crispr Therapeutics AG (CRSP) Receives a Buy from William Blair
01:18am, Wednesday, 29'th Apr 2020
William Blair analyst Raju Prasad maintained a Buy rating on Crispr Therapeutics AG (CRSP) yesterday. The company's shares closed last Tuesday at $52.52.
Crispr Therapeutics AG (CRSP) Receives a Buy from William Blair
01:18am, Wednesday, 29'th Apr 2020
William Blair analyst
Raju Prasad
maintained a
Buy
rating on Crispr Therapeutics AG (
CRSP
–
Research Report
) yesterday. The company’s shares closed last Tuesday at $52.52.
According to
TipRanks.
Mirum Appoints Global Blood's Radovich as Its Chief Operating Officer
10:26pm, Tuesday, 28'th Apr 2020
Mirum Pharmaceuticals (NASDAQ: ]) has added Peter Radovich to its C-suite as its chief operating officer. Radovich was most recently executive vice
PTC Therapeutics (PTCT) Receives a Buy from William Blair
08:06pm, Tuesday, 28'th Apr 2020
William Blair analyst Raju Prasad maintained a Buy rating on PTC Therapeutics (PTCT) today. The company's shares closed last Tuesday at $53.80. According
PTC Therapeutics (PTCT) Receives a Buy from William Blair
08:06pm, Tuesday, 28'th Apr 2020
William Blair analyst
Raju Prasad
maintained a
Buy
rating on PTC Therapeutics (
PTCT
–
Research Report
) today. The company’s shares closed last Tuesday at $53.80.
According to
TipRanks.com
, Pras
Morgan Stanley Believes Zentalis Pharmaceuticals (ZNTL) Still Has Room to Grow
12:37pm, Tuesday, 28'th Apr 2020
In a report released today, Matthew Harrison from Morgan Stanley initiated coverage with a Buy rating on Zentalis Pharmaceuticals (ZNTL). The company's
Wells softens view on Edwards Lifesciences in premarket analyst action
11:32am, Tuesday, 28'th Apr 2020
Adverum Biotechnologies (NASDAQ:ADVM) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs.Alector (NASDAQ:ALEC) initiated with Buy rating and $32 (21% upside) price target at
Global Blood Therapeutics initiated with a Buy at Stifel GBT;NVS
09:19am, Monday, 27'th Apr 2020
Global Blood Therapeutics initiated with a Buy at Stifel Stifel GBT NVS
Global Blood Therapeutics (NASDAQ:GBT) Trading 11.9% Higher
06:18am, Sunday, 26'th Apr 2020
Global Blood Therapeutics Inc (NASDAQ:GBT)’s stock price traded up 11.9% during mid-day trading on Friday . The stock traded as high as $81.54 and last traded at $80.29, 1,821,218 shares were traded
Insider Selling: Global Blood Therapeutics Inc (NASDAQ:GBT) Insider Sells 4,080 Shares of Stock
10:34am, Friday, 24'th Apr 2020
Global Blood Therapeutics Inc (NASDAQ:GBT) insider Tricia Borga Suvari sold 4,080 shares of the business’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an aver
